TEIKYO UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1996-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.teikyo-u.ac.jp
Prospective Multicenter Registry of Hybrid Coronary Artery Revascularization Combined With Surgical Bypass and Percutaneous Coronary Intervention Using Everolimus Eluting Metallic Stents
Phase 4
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Coronary artery bypass graftingProcedure: Percutaneous coronary intervention
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2016-09-09
- Lead Sponsor
- Teikyo University
- Target Recruit Count
- 100
- Registration Number
- NCT02894255
3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: Thienopyridine
- First Posted Date
- 2016-07-19
- Last Posted Date
- 2016-08-02
- Lead Sponsor
- Teikyo University
- Target Recruit Count
- 1500
- Registration Number
- NCT02837003
- Locations
- π―π΅
Teikyo University Hospital, Tokyo, Japan
Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
Completed
- Conditions
- Primary Biliary Cirrhosis
- First Posted Date
- 2016-01-20
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- Teikyo University
- Target Recruit Count
- 44
- Registration Number
- NCT02659696
- Locations
- π―π΅
Teikyo University School of Medicine, Tokyo, Please Select, Japan
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer
Phase 1
- Conditions
- Esophageal Cancer
- Interventions
- Biological: URLC10, TTK, KOC1, VEGFR1, VEGFR2, cisplatin, fluorouracil
- First Posted Date
- 2008-03-10
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Teikyo University
- Target Recruit Count
- 9
- Registration Number
- NCT00632333
- Locations
- π―π΅
Teikyo University, 2-11-1 Kaga Itabashi-ku, Tokyo, Japan
Β© Copyright 2025. All Rights Reserved by MedPath